Trials / Completed
CompletedNCT02392312
Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant Recipients
Safety and Efficacy of Individual Batches of ATG-F in Kidney Transplant Recipients: Multicentre, Prospective, Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 950 (actual)
- Sponsor
- Astellas Pharma China, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A multicenter, prospective, observational study to evaluate the safety and efficacy of individual batches of ATG-F in kidney transplant recipients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ATF-Fresenius S | intravenous |
Timeline
- Start date
- 2015-01-21
- Primary completion
- 2018-03-16
- Completion
- 2018-03-16
- First posted
- 2015-03-18
- Last updated
- 2024-10-21
Locations
25 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02392312. Inclusion in this directory is not an endorsement.